3.5. Serum CRP and Urinary CTX-II Levels
Analyses of changes in serum CRP and urinary CTX-II levels showed no statistically significant differences between FP-MD and placebo groups after 12 weeks of intake. Serum CRP level after 12 weeks of intake using the PP set showed a mean decrease of 0.04 ± 0.22 mg/dL (